§ 13F · FUND PROFILE
Atlas Venture Life Science Advisors, LLC.
AUM · $881M (13F)Positions · 7Turnover · n/a · Q2Filed · Aug 13, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$114M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 13, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | KYMR | Kymera Therapeutics, Inc. | 2.85M | $327M | 37.1% | −38% |
| 2 | DYN | Dyne Therapeutics, Inc. | 6.80M | $151M | 17.1% | −26% |
| 3 | SION | Sionna Therapeutics, Inc. | 3.00M | $132M | 15.0% | ±0% |
| 4 | KLRA | Kailera Therapeutics, Inc. | 5.17M | $114M | 12.9% | NEW |
| 5 | IRON | Disc Medicine, Inc. | 1.51M | $111M | 12.6% | ±0% |
| 6 | QTTB | Q32 Bio, Inc. | 2.72M | $35M | 3.9% | +30% |
| 7 | KRRO | Korro Bio, Inc. | 963K | $13M | 1.4% | −15% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ATLAS SIGNAL
AC read
Atlas Venture Life Science Advisors, LLC is a Other fund managing $881 million in assets. The fund runs a focused portfolio of just 7 positions.
Read the full dossier →